These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Suh-Burgmann E Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124 [TBL] [Abstract][Full Text] [Related]
10. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort. Reddihalli PV; Subbian A; Umadevi K; Rathod PS; Krishnappa S; Nanaiah SP; Bafna UD Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():17-21. PubMed ID: 26142911 [TBL] [Abstract][Full Text] [Related]
11. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96. Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331 [TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma. Li H; Hong W; Zhang R; Wu L; Liu L; Zhang W Chin Med J (Engl); 2002 Oct; 115(10):1496-500. PubMed ID: 12490095 [TBL] [Abstract][Full Text] [Related]
13. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249 [TBL] [Abstract][Full Text] [Related]
14. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Silva EG; Gershenson DM; Malpica A; Deavers M Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075 [TBL] [Abstract][Full Text] [Related]
15. Fertility-sparing surgery for ovarian low malignant potential tumors. Rao GG; Skinner EN; Gehrig PA; Duska LR; Miller DS; Schorge JO Gynecol Oncol; 2005 Aug; 98(2):263-6. PubMed ID: 15964063 [TBL] [Abstract][Full Text] [Related]
16. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients. Bonazzi C; Peccatori F; Colombo N; Lucchini V; Cantù MG; Mangioni C Obstet Gynecol; 1994 Oct; 84(4):598-604. PubMed ID: 7522313 [TBL] [Abstract][Full Text] [Related]
17. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery. Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695 [TBL] [Abstract][Full Text] [Related]
18. Malignant ovarian germ cell tumor in King Chulalongkorn Memorial Hospital. Lertkhachonsuk R; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Tresukosol D J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S124-8. PubMed ID: 16623016 [TBL] [Abstract][Full Text] [Related]
19. Immature teratoma of the ovary: a clinicopathological study of 28 cases. Deodhar KK; Suryawanshi P; Shah M; Rekhi B; Chinoy RF Indian J Pathol Microbiol; 2011; 54(4):730-5. PubMed ID: 22234099 [TBL] [Abstract][Full Text] [Related]
20. [Clinical features and prognostic factors of malignant ovarian teratoma]. Jin FM; Zhu GZ; Feng YJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):427-30. PubMed ID: 12974088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]